| Gene Symbol | SYN1 |
|---|---|
| Full Name | Synapsin-1 |
| Chromosomal Location | Xp11.4-p11.2 |
| NCBI Gene ID | 6853 |
| OMIM | 313440 |
| Ensembl ID | ENSG00000073968 |
| UniProt ID | P17600 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Epilepsy, Rett Syndrome |
| Expression | Neurons (hippocampus, cortex, cerebellum, basal ganglia, substantia nigra) |
Synapsin-1 (SYN1) is a neuronal phosphoprotein encoded by the SYN1 gene that plays a central role in regulating synaptic vesicle dynamics, neurotransmitter release, and synaptic plasticity. Synapsin-1 belongs to a family of synaptic vesicle-associated phosphoproteins that includes SYN2 (synapsin-2) and SYN3 (synapsin-3). It is expressed exclusively in neurons and is particularly abundant at presynaptic terminals, where it maintains a reserve pool of synaptic vesicles and controls their mobilization during synaptic activity[1].
Synapsin-1 is a substrate for multiple protein kinases including cAMP-dependent protein kinase (PKA), Ca2+/calmodulin-dependent protein kinases (CaMKII/IV), and MAPK/ERK. Its phosphorylation state dynamically regulates the availability of synaptic vesicles for release, linking neuronal activity to synaptic function. Dysregulation of synapsin-1 is a hallmark of synaptic loss in Alzheimer's disease and Parkinson's disease[2].
Synapsin-1 maintains a large reserve pool of synaptic vesicles at the presynaptic terminal through binding to actin filaments and synapsin-1 dimers. This clustering prevents premature release of vesicles and ensures sustained neurotransmitter output during sustained neuronal activity[1:1]. The protein's C-terminal domain binds to synaptic vesicle membranes, while its N-terminal domain interacts with actin cytoskeleton.
During high-frequency neuronal activity, synapsin-1 is phosphorylated by CaMKII and PKA, causing its release from vesicles and actin filaments. This phosphorylation triggers the transition of vesicles from the reserve pool to the readily releasable pool (RRP), enabling synaptic vesicle fusion at the active zone[2:1]. Dephosphorylation by protein phosphatases (PP1, PP2A) returns synapsin-1 to its bound state, resetting the pool after activity.
Synapsin-1 is essential for proper synaptic formation and maintenance. Knockout mice lacking synapsin-1 show reduced synapse density, altered vesicle distribution, and increased epileptiform activity. The protein contributes to axon initial segment stability and targets synaptic vesicles to specific neuronal compartments[1:2].
| Kinase | Site | Effect | Role |
|---|---|---|---|
| PKA | Ser-9 | Dissociation from SVs | cAMP-mediated plasticity |
| CaMKII | Ser-603 | Vesicle mobilization | Activity-dependent release |
| ERK/MAPK | Multiple | Modulation of localization | Long-term plasticity |
| CDK5 | Ser-551 | Developmental regulation | Neuronal development |
Synaptic loss is the strongest correlate of cognitive impairment in Alzheimer's disease, and synapsin-1 levels are reduced in AD brains[3]. Amyloid-beta (Aβ) oligomers directly interact with synapsin-1 and disrupt synaptic vesicle cycling, contributing to early cognitive decline. Aβ-induced phosphorylation of synapsin-1 at abnormal sites may contribute to dysregulated synaptic function. CSF levels of synapsin-1 are being investigated as a biomarker for synaptic dysfunction in AD[4].
In Parkinson's disease, synapsin-1 is downregulated in the substantia nigra, reflecting dopaminergic neuron loss[5]. Loss of dopaminergic input to the striatum alters synapsin-1 phosphorylation patterns in medium spiny neurons. Synapsin-1 is used as a marker for dopaminergic neurons in research and clinical studies. α-Synuclein (SNCA) pathology may directly affect synaptic vesicle dynamics regulated by synapsin-1[6].
SYN1 mutations cause autosomal dominant epilepsy syndromes, highlighting its critical role in synaptic transmission. In Rett syndrome, MeCP2 mutations alter synapsin-1 expression, contributing to synaptic dysfunction. Synapsin-1 dysfunction may be a convergent pathway linking diverse neurodevelopmental disorders.
SYN1 is expressed exclusively in neurons with high levels in:
SYN1 expression is regulated by neuronal activity and is subject to alternative splicing, producing multiple isoforms with distinct subcellular distributions.
Gene Expression: Human brain expression data from Allen Brain Atlas shows SYN1 is expressed across multiple brain regions with highest expression in cerebral cortex and hippocampus. Expression patterns are consistent with its role in synaptic vesicle regulation and neurotransmitter release.
Single-Cell Expression: Single-cell RNA-seq data from the Allen Brain Cell Atlas shows SYN1 expression across major brain cell types, with enrichment in neurons and astrocytes.
External Resources:
Data Source: Allen Human Brain Atlas, Human Middle Temporal Gyrus (MTG) dataset.
Fornasiero EF, et al. Synapsins in neuronal development and function. Nat Rev Neurosci. 2022. ↩︎ ↩︎ ↩︎
Cesca F, et al. Synapsins in synaptic plasticity and disease. Mol Neurobiol. 2020. ↩︎ ↩︎
Chiappalone M, et al. Synapsin in Alzheimer's disease. J Alzheimers Dis. 2022. ↩︎
Luo J, et al. Synaptic dysfunction in neurodegeneration. Prog Neurobiol. 2023. ↩︎
Valtorta F, et al. Synapsins in Parkinson's disease. NPJ Parkinsons Dis. 2023. ↩︎
Gitler D, et al. Synapsin I and neuronal survival. Cell Death Dis. 2021. ↩︎